Showing results (541-550 of 597) with videos related to
Sort By:
Pageof 60
Molecular Pharmaceutics|October 30, 2010
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosisMark E Lobatto, Zahi A Fayad, Stephane Silvera, et al.Cardiovascular Research|July 26, 2024
Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosisYang Xu, Adam Korayem, Ana S Cruz-Solbes, et al.JACC. Clinical Electrophysiology|June 24, 2023
Interatrial Block Association With Adverse Cardiovascular Outcomes in Patients Without a History of Atrial FibrillationJoshua Lampert, David Power, Shreyas Havaldar, et al.Journal of the American College of Cardiology|August 20, 2016
Association Between a Social-Business Eating Pattern and Early Asymptomatic AtherosclerosisJosé L Peñalvo, Leticia Fernández-Friera, Beatriz López-Melgar, et al.Journal of the American Heart Association|May 31, 2024
Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft SurgeryAnoop N Koshy, Gregg W Stone, Samantha Sartori, et al.Cardiovascular Drugs and Therapy|June 15, 2023
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without DiabetesMaeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, et al.Journal of the American Heart Association|October 24, 2019
Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary SyndromesErika Yamamoto, Taishi Yonetsu, Tsunekazu Kakuta, et al.European Heart Journal. Imaging Methods and Practice|June 22, 2026
Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudyPruthvi C Revaiah, Yuliya Vengrenyuk, JiaJia Liu, et al.Lancet (London, England)|September 1, 2021
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysisPhilip Joseph, Gholamreza Roshandel, Peggy Gao, et al.JACC. Cardiooncology|February 19, 2025
SGLT2i Therapy Prevents Anthracycline-Induced Cardiotoxicity in a Large Animal Model by Preserving Myocardial EnergeticsDanielle Medina-Hernández, Laura Cádiz, Annalaura Mastrangelo, et al.Pageof 60